SLC2A1 and glioblastoma: In glioblastoma patients pre-RT, the mean ± SD of serum GLUT-1 was 9.0 ± 1.64 that was increased to 10.65 ± 2.0 post-RT, while it was 7.63 ± 0.73 in healthy controls.